Cargando…

Efficacy and Toxicity of Whole Pelvic Radiotherapy Versus Prostate-Only Radiotherapy in Localized Prostate Cancer: A Systematic Review and Meta-Analysis

BACKGROUND: There is little level 1 evidence regarding the relative efficacy and toxicity of whole pelvic radiotherapy (WPRT) compared with prostate-only radiotherapy (PORT) for localized prostate cancer. METHODS: We used Cochrane, PubMed, Embase, Medline databases, and ClinicalTrials.gov to systema...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Shilin, Tang, Wen, Luo, Huanli, Jin, Fu, Wang, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828576/ https://www.ncbi.nlm.nih.gov/pubmed/35155197 http://dx.doi.org/10.3389/fonc.2021.796907

Ejemplares similares

The Early Result of Whole Pelvic Radiotherapy and Stereotactic Body Radiotherapy Boost for High-Risk Localized Prostate Cancer
por: Lin, Yu-Wei, et al.
Publicado: (2014)

Postoperative radiotherapy for prostate cancer: Morbidity of local-only or local-plus-pelvic radiotherapy
por: Waldstein, Cora, et al.
Publicado: (2017)

Whole Pelvic Radiotherapy With Stereotactic Body Radiotherapy Boost vs. Conventionally Fractionated Radiotherapy for Patients With High or Very High-Risk Prostate Cancer
por: Wang, Shih-Chang, et al.
Publicado: (2020)

The role of image-guided radiotherapy in prostate cancer: A systematic review and meta-analysis
por: Wang, Shilin, et al.
Publicado: (2022)

Two-Year Toxicity and Efficacy of Carbon Ion Radiotherapy in the Treatment of Localized Prostate Cancer: A Single-Centered Study
por: Li, Ping, et al.
Publicado: (2022)

Dosimetric and Hematologic Implications of Prostate-Only Versus Whole Pelvic Radiotherapy: Results of the Multicentric Phase 3 PROPER Study
por: Fonteyne, Valérie, et al.
Publicado: (2023)

A retrospective comparison of outcome and toxicity of preoperative image-guided intensity-modulated radiotherapy versus conventional pelvic radiotherapy for locally advanced rectal carcinoma
por: Huang, Chun-Ming, et al.
Publicado: (2017)

The Distribution of Pelvic Nodal Metastases in Prostate Cancer Reveals Potential to Advance and Personalize Pelvic Radiotherapy
por: Filimonova, Irina, et al.
Publicado: (2021)

Prostate-specific antigen kinetics after stereotactic body radiotherapy as monotherapy or boost after whole pelvic radiotherapy for localized prostate cancer
por: Kim, Hun Jung, et al.
Publicado: (2015)

Toxicity and Patient-Reported Outcomes of a Phase 2 Randomized Trial of Prostate and Pelvic Lymph Node Versus Prostate only Radiotherapy in Advanced Localised Prostate Cancer (PIVOTAL)
por: Dearnaley, David, et al.
Publicado: (2019)

Patterns of Bone Failure in Localized Prostate Cancer Previously Irradiated: The Preventive Role of External Radiotherapy on Pelvic Bone Metastases
por: Grapin, Mathieu, et al.
Publicado: (2019)

Cost-effectiveness analysis of ultra-hypofractionated radiotherapy and conventionally fractionated radiotherapy for intermediate- to high-risk localized prostate cancer
por: He, Jiaoxue, et al.
Publicado: (2023)

Incidence and associated factors of developing second pelvic malignant neoplasms among prostate cancer patients treated with radiotherapy
por: Wang, Youbiao, et al.
Publicado: (2023)

Big Data Analytics for Prostate Radiotherapy
por: Coates, James, et al.
Publicado: (2016)

MR-Guided Radiotherapy for Prostate Cancer
por: Tocco, Boris R., et al.
Publicado: (2020)

Editorial: Advances in radiotherapy for prostate cancer
por: Kamran, Sophia C., et al.
Publicado: (2022)

Effect of Abdominal Circumference on the Irradiated Bowel Volume in Pelvic Radiotherapy for Rectal Cancer Patients: Implications for the Radiotherapy-Related Intestinal Toxicity
por: Wang, Gang, et al.
Publicado: (2022)

A prospective comparison of acute intestinal toxicity following whole pelvic versus small field intensity-modulated radiotherapy for prostate cancer
por: Kim, Yeon Joo, et al.
Publicado: (2016)

Radiotherapy plus immune checkpoint inhibitor in prostate cancer
por: Li, Tianjie, et al.
Publicado: (2023)

Bulk Anatomical Density Based Dose Calculation for Patient-Specific Quality Assurance of MRI-Only Prostate Radiotherapy
por: Choi, Jae Hyuk, et al.
Publicado: (2019)

Automated volumetric modulated arc therapy planning for whole pelvic prostate radiotherapy
por: Buschmann, Martin, et al.
Publicado: (2017)

Local Dose Effects for Late Gastrointestinal Toxicity After Hypofractionated and Conventionally Fractionated Modern Radiotherapy for Prostate Cancer in the HYPRO Trial
por: Heemsbergen, Wilma D., et al.
Publicado: (2020)

Editorial: Stereotactic body radiotherapy for prostate cancer
por: Kishan, Amar U., et al.
Publicado: (2022)

Efficacy of PSMA PET-Guided Radiotherapy for Oligometastatic Castrate-Resistant Prostate Cancer
por: Henkenberens, Christoph, et al.
Publicado: (2021)

Comparison of toxicities between ultrahypofractionated radiotherapy versus brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer
por: Yamazaki, Hideya, et al.
Publicado: (2022)

Comparison of Oncological Outcomes Between Radical Prostatectomy and Radiotherapy by Type of Radiotherapy in Elderly Prostate Cancer Patients
por: Guo, Xiao-Xiao, et al.
Publicado: (2021)

Prostate only radiotherapy using external beam radiotherapy: A clinician’s perspective
por: Lee, Jeong Won, et al.
Publicado: (2022)

Feasibility and Outcome of PSMA-PET-Based Dose-Escalated Salvage Radiotherapy Versus Conventional Salvage Radiotherapy for Patients With Recurrent Prostate Cancer
por: Vogel, Marco M. E., et al.
Publicado: (2021)

Clinical Efficacy and Safety of Proton and Carbon Ion Radiotherapy for Prostate Cancer: A Systematic Review and Meta-Analysis
por: Li, Meixuan, et al.
Publicado: (2021)

Single-Center Experience of Focal Thermo-Ablative Therapy After Pelvic Radiotherapy for In-Field Prostate Cancer Oligo-Recurrence
por: Giraud, Nicolas, et al.
Publicado: (2021)

Whole-pelvic volumetric-modulated arc therapy for high-risk prostate cancer: treatment planning and acute toxicity
por: Ishii, Kentaro, et al.
Publicado: (2015)

Survival in Patients With Metastatic Prostate Cancer Undergoing Radiotherapy: The Importance of Prostate-Specific Antigen-Based Stratification
por: Tian, Zijian, et al.
Publicado: (2021)

Planning With Patient-Specific Rectal Sub-Region Constraints Decreases Probability of Toxicity in Prostate Cancer Radiotherapy
por: Lafond, Caroline, et al.
Publicado: (2020)

Predictive modelling for late rectal and urinary toxicities after prostate radiotherapy using planned and delivered dose
por: Ong, Ashley Li Kuan, et al.
Publicado: (2022)

Ultrahypofractionated Radiotherapy versus Conventional to Moderate Hypofractionated Radiotherapy for Clinically Localized Prostate Cancer
por: Yamazaki, Hideya, et al.
Publicado: (2021)

Survival Significance of Patients With Low Prostate-Specific Antigen and High-Grade Prostate Cancer After Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy
por: Guo, Yadong, et al.
Publicado: (2019)

Phase II Trial of Pure Hypofractionated Radiotherapy in the Treatment of Localized Carcinoma of the Prostate
por: Gopaul, Darin, et al.
Publicado: (2018)

Is pelvic prophylactic radiotherapy in prostate cancer just right?
por: Taussky, Daniel, et al.
Publicado: (2020)

Hybrid Tomo‐Helical and Tomo‐Direct radiotherapy for localized prostate cancer
por: Karaca, Sibel, et al.
Publicado: (2021)

Landscape of Carbon Ion Radiotherapy in Prostate Cancer: Clinical Application and Translational Research
por: Chen, Xue, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_35gtf1lmeu13m8n3eb9u3oihql